shareholdersunite.com

Opportunities in smallcaps

shareholdersunite.com header image 2

BioLife Will Suffer From Cancellations Of Trials

April 11th, 2020 · No Comments

  • The shares in BioLife Solutions have crashed with the markets and some minor disappointments in quarterly figures.
  • But we think the company has several secular tailwinds blowing in its favor and we see attractive valuation at these levels.
  • There are signs that clinical trials are aborted because of the strain on the healthcare system, which is a negative.
  • We do think the shares offer good value for investors with a longer-time horizon at these levels.

Source: BioLife Will Suffer From Cancellations Of Trials (NASDAQ:BLFS) | Seeking Alpha

Tags: BLFS